Serum beta 2-microglobulin in lymphoproliferative and myeloproliferative diseases (Q40200527)

18 September 2017

1 reference

title

Serum beta 2-microglobulin in lymphoproliferative and myeloproliferative diseases (English)

1 reference

18 September 2017

Child JA

1

1 reference

PubMed ID

6396193

18 September 2017

Kushwaha MR

series ordinal

2

1 reference

PubMed ID

6396193

18 September 2017

language of work or name

1 reference

1 October 1984

1 reference

18 September 2017

Hematological Oncology

1 reference

18 September 2017

2

1 reference

18 September 2017

4

1 reference

18 September 2017

391-401

1 reference

Serum β2 microglobulin and its prognostic value in lymphomas

18 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

The suppressor-cell network in cancer (second of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

Evaluation of serum β 2-microglobulin as a prognostic indicator in myelomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

Immunological identity of the small subunit of HL-A antigens and beta2-microglobulin and its turnover on the cell membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

Serum β2-microglobulin in various disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

Enhanced expression of HLA antigens and β2-microglobulin on interferon-treated human lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

Beta2-microglobulin: occurrence in fetal life and malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

Elevation of serum beta 2-microglobulin levels during infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

Beta2 microglobulin and lymphocytic infiltration in Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

Serum β 2-microglobulin in myelomatosis: potential value in stratification and monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

β2-Microglobulin levels in cancerous and other disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

Elevated Salivary and Synovial Fluid β 2 -Microglobulin in Sjogren's Syndrome and Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

Serum β2-microglobulin in controls and cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

Activation of Suppressor T Cells during Epstein-Barr-Virus-Induced Infectious Mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

Quantitation of beta2-microglobulin and HLA on the surface of human cells. II. In vitro cell lines and their hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

Serum 2 -microglobulin in renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

Microglobulinaemia in Renal Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

Serum β2-microglobulin in patients with non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Serum beta-2-microglobulin in multiple myeloma: Relation to presenting features and clinical status

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Serum beta2microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Elevation of serum β2 microglobulin in liver diseases

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

beta 2 Microglobulin, a tumour marker of lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas findings in a multicenter study and experience in selected patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Plasma beta-2-microglobulin and fibronectin levels in beta-thalassaemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Beta-2-microglobulin in sickle cell anaemia. Evidence of increased tubular reabsorption

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Reappraisal of plateau phase in myeloma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Serum Beta2-Microglobulin in Acute and Chronic Leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Beta-2 microglobulin: A sensitive non-specific marker of acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Serum beta 2-microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Serum beta 2-microglobulin in malignant lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Total Tumour Mass Score (TTM): a New Parameter in Chronic Lymphocytic Leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

T-CELL SUBSETS IN B-CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma: relationship to treatment and clinical stage

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Serum beta-2-microglobulin in disorders of myeloid proliferation

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Plasma beta 2-microglobulin levels in bone marrow transplant patients with cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Prognostic significance of pretreatment serum β2-microglobulin levels in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Association of Herpesvirus Infections with T-Lymphocyte-Subset Alterations, Glomerulopathy, and Opportunistic Infections after Renal Transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

3H-thymidine uptake in chronic lymphocytic leukaemia cells

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Behaviour of serum beta 2-microglobulin and acute phase reactant proteins in chronic lymphocytic leukaemia. A multicentre study

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900020409

7 January 2021

Identifiers

DOI

10.1002/HON.2900020409

1 reference

18 September 2017

1 reference

PubMed ID

6396193